COVID-19 vaccine: Johnson & Johnson begins two-dose trial of its vaccine
New York: Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine ...
Read moreDetails
New York: Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine ...
Read moreDetails
By Dilip Cherian Scratch the surface of sarkari rules, and they quickly become about power, career pathways, and the familiar...
Read moreDetails
The fresh Indo-US trade deal announced by US President Donald Trump 2 February will see American tariffs on Indian goods...
Read moreDetails
China’s President Xi Jinping now finds himself in an enviable position enjoying kind of a special superpower status as countries,...
Read moreDetails
For an economy plagued by multiple ailments – a daily depreciating currency, growing household debt, high unemployment and inequality, exodus...
Read moreDetails